Hepatitis C Clinical Trial
Official title:
DVD-based HIV/HCV Intervention for Drug-Involved Latino Criminal Justice Clients
The purpose of the study are the following: 1) Pilot test and conduct baseline and 3 month
follow up assessments to evaluate the preliminary efficacy of the DVD-based HIV/HCV
intervention by randomly assigning 210 Latino corrections-involved, outpatient abuse
treatment clients to either the experimental intervention or to a wait list control group;
and 2) to evaluate both participant and interventionist acceptability of this novel
DVD-based intervention.
They study hypothesis are the following:
1. participants in the intervention condition will report greater reductions in sexual
risk behaviors (e.g., unprotected sexual contact) from baseline to 3 month follow-up
compared to the control group;
2. participants will report greater reductions in drug risk behaviors (e.g., sharing
injection equipment, drug use during sex) from baseline to 3 month follow-up compared
to the control group;
3. participants who report more HIV prevention information, motivation, and behavioral
skills will report fewer sexual risk behaviors.
Status | Completed |
Enrollment | 201 |
Est. completion date | May 2016 |
Est. primary completion date | May 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 49 Years |
Eligibility |
Inclusion Criteria: - must be between 18 - 49 years of age - self-identify as Hispanic or Latino - be involved in the criminal justice system - report a history of drug use - be in an outpatient substance abuse program - self-identify as heterosexual Exclusion Criteria: - be HIV positive - be cognitively impaired |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | University of Delaware Center for Drug and Alcohol Studies | Coral Gables | Florida |
Lead Sponsor | Collaborator |
---|---|
University of Delaware | National Institute on Drug Abuse (NIDA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sexual risk behaviors | 90 days | Yes | |
Secondary | Drug Use Behaviors | 90 days | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Recruiting |
NCT04510246 -
Link Hepatitis C Notifications to Treatment in Tasmania
|
N/A | |
Completed |
NCT03413696 -
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
|
||
Completed |
NCT03118674 -
Harvoni Treatment Porphyria Cutanea Tarda
|
Phase 2 | |
Completed |
NCT03109457 -
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma
|
||
Completed |
NCT01458054 -
Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults
|
Phase 1 | |
Completed |
NCT03740230 -
An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs
|
||
Completed |
NCT03426787 -
Helping Empower Liver and Kidney Patients
|
N/A | |
Completed |
NCT03627299 -
Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors
|
Phase 4 | |
Completed |
NCT00006301 -
Immune Response to Hepatitis C Virus
|
||
Active, not recruiting |
NCT03949764 -
The Kentucky Viral Hepatitis Treatment Study
|
Phase 4 | |
Completed |
NCT03365635 -
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
|
Phase 4 | |
Recruiting |
NCT04405024 -
Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients
|
N/A | |
Completed |
NCT04525690 -
Improving Inpatient Screening for Hepatitis C
|
N/A | |
Completed |
NCT04033887 -
Evaluation Study of RDTs Detecting Antibodies Against HCV
|
||
Withdrawn |
NCT04546802 -
HepATocellular Cancer Hcv Therapy Study
|
Phase 3 | |
Active, not recruiting |
NCT02961426 -
Strategic Transformation of the Market of HCV Treatments
|
Phase 2/Phase 3 | |
Completed |
NCT02992184 -
PoC-HCV Genedrive Viral Detection Assay Validation Study
|
N/A | |
Completed |
NCT02705534 -
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
|
Phase 3 | |
Completed |
NCT02869776 -
Integrating HCV and HIV Screening During the Era of HIV Antigen Testing
|
N/A |